top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Drugs 2021
Anticancer Drugs 2021
Autore Meegan Mary J
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (594 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 1,2,3-triazole
1,3,4-oxadiazole
3-amino-4'-guanidino
3,4'-bis-guanidino
5-fluoruracil
7-deaza-4'-thioadenosine derivatives
acetamide
adamantane
ADC (antibody-drug conjugate)
age
alkylated
anticancer
anticancer activity
anticancer agents
apoptosis
apoptosis induction
aromatase inhibitor
Bcl-2 inhibitors
benzenesulfonamides
benzimidazole
BRAF
breast cancer
cancer
cancer cell viability
cancer vaccine
CAR (chimeric antigen receptor)
cardiotoxicity
carvedilol
cell cycle analysis
chalcone
chalcones
colony formation
combretastatin A-4
concentration-guided dosing
covalent binding
CovDock
cumulative dose
cyclophosphamide
cytotoxic activity
cytotoxic agents
cytotoxicity
designed multiple ligand
diphenyl ether
DNA fragmentation
docking
doxazosin
drug efflux
dual inhibitors
dual-targeting molecule
EGFR
ELISA
enantioselective synthesis
entrectinib
exportin-1
gastric adenocarcinoma
generic product
H1299
HDAC inhibitors
HER2
heterocyclic compound
histopathology
HL-60
HT-29 cells
hybrid compounds
hybrid molecule
hydrazide derivatives
imidazoles
Imiquimod
immunotherapy
in vitro
in vivo
indazole
Indole-based analogues
inflammation
interleukin-6
intramolecular hydrogen bond
isolation
kidney
larotrectinib
letrozole
MD simulations
MDA-MB-231 cells
mechanism prediction
miR-21
mitoxantrone
model informed dosing
MTT cytotoxic assay
MUC1
MUC16
mucin
multi-kinase inhibitor
multidrug resistance
n/a
NaMSA
nitrogen scaffolds
NTRK
nucleoside
oxidative stress
patent review
pemetrexed
phenstatin
phenyl pyridyl ether
physiologically based pharmacokinetics
protein kinase inhibitors
resin acid
solid/lipid nanoparticles
sorafenib
STAT inhibitors
synthesis
TDP1
testis
thieno[2,3-d][1,2,3]triazine
thiourea
thymidylate synthase
tissue-agnostic
Toll-Like Receptor
toxicity
Trk
Trk fusion
trypan blue assay
tryptophanol
tubulin polymerisation inhibitor
tumor spheroids
tyrosil-DNA-phosphodiesterase 1
urinary bladder
USFDA
xanthone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576874303321
Meegan Mary J  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Coumarin and Its Derivatives
Coumarin and Its Derivatives
Autore Matos Maria João
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (406 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 3-aroylcoumarines
4-hydroxy-7-methoxycoumarin
4-hydroxycoumarin
6'-(4-biphenyl)-β-iso-cinchonine
acenocoumarol
adenosine receptors
analytical methods
anti-HIV
antibacterial activity
anticancer activity
anticoagulation
antiplatelet activity
apoptosis
autophagy
benzopyrones
benzyl 2,3-butadienoate
binding affinity
bioactivity
biological applications
biosynthesis
biotransformation
calanolide A
calanolides
Calophyllaceae
Calophyllum
chalcocoumarin
chalcone
chalepensin
chalepin
charge transfer
cholinesterase inhibition
cholinesterases
Chromobacterium violaceum
complementary therapies
constitutive androstane receptor
coumarin
coumarin dyes
coumarin3-carboxamides
coumarins
COX
Crohn's disease
curcumin
curcumin-coumarin hybrids
dihydrocoumarin-fused dihydropyranones
direct laser write
docking
docking simulation
drug discovery
dye-sensitized solar cells
electrophilic compounds
Escherichia coli
esculetin
esculin
ethynylaryl
ferulenol
five-membered aromatic heterocycles
fluorescent probes
free radical polymerization
furan
glutathione
glycyrol
Glycyrrhiza uralensis
human monoamine oxidases
hydroxyl-modified coumarin
imidazole
immunoproteasome
impedance aggregometry
in silico studies
in silico tools
inflammation
inflammatory bowel disease
intestinal inflammation
isocoumarin
kinetics
LED
liquiritigenin
macrophage
MAO-B
MAPK
mechanical valve
model plant
molecular dynamics
monoamine oxidase inhibition
n/a
natural genetic variation
natural products
neurodegenerative diseases
neuroprotection
NF-κB
non-nucleoside reverse transcriptase inhibitors (NNRTIs)
non-peptidic
osthole
oxazole
oxidative stress
photocomposites
photophysical
plant-derived molecules
polyphenols
pseudocalanolides
psoralen core
pyranocoumarins
pyrazole
pyrrole
QS inhibitors
quorum sensing
reverse transcriptase
Ruta chalepensis
Rutaceae
scavenging activity
scoparone
selenophen
simple coumarins
sorafenib
structural annotation
thermal and structural characterization
thiadiazole
thiazole
thieno [3,2-b] thiophene
thiophene
time in therapeutic range
triazole
ulcerative colitis
umbelliferone
warfarin
warhead scan
Yin Chen Hao
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557577003321
Matos Maria João  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
PLGA Based Drug Carrier and Pharmaceutical Applications
PLGA Based Drug Carrier and Pharmaceutical Applications
Autore Pereira Maria Carmo
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (328 p.)
Soggetto topico Medicine
Soggetto non controllato 17-βestradiol release
activation
aggregation
alginate
binding
biodegradable polymers
BMP-2
BMP-2-microspheres
bone regeneration
cancer
cellular uptake
CHO-K1 cells
cisplatin
colorectal cancer
controlled drug release
controlled release
core-shell nanoparticles
dexamethasone
double emulsion approach
drug delivery
drug delivery systems
drug release
electron microscopy
electroporation
experimental design
folic acid
formulation development
fractional factorial design
gadolinium
gastrointestinal tract
glioblastoma multiforme
Huntington's disease
hydrogel
hydrogel system
hydroxy-stearic acid
in vivo imaging
intra-abdominal anti-adhesion barrier
intra-articular injection
joint retention
LED
local delivery
magnetic resonance imaging
magnetic targeting
mesenchymal stromal cells
microcapsules
microcarriers
microcrystal
microfluidics
microparticles
microsphere
microspheres
molecular mobility
multimodal imaging
n/a
nano-CT
nanomedicine
nanoparticles
nanoscaled drug delivery
NSAIDs
O6-methylguanine DNA methyltransferase (MGMT) protein
oleogels
ophthalmic drug delivery
osteoporosis
oxaliplatin
paclitaxel
photoluminescence
PLA
platelet
PLGA
PLGA microsphere
PLGA nanocapsules
PLGA nanoparticles
PLGA-NPs
PLGA-PEG
Pluronic F68
poly-lactide-co-glycolide
polylactic acid
polymeric film
polymeric nanocarrier
reactive oxygen species
risperidone
serum stability
silicon
siRNA
SKOV-3 cells
smart nanocarriers
sorafenib
spray-drying technique
systemic exposure
terahertz spectroscopy
theranostic cargo
theranostic nanoparticles
theranostics
three-dimensional X-ray imaging
tissue engineering
tocopherol
topical drug delivery
triamcinolone acetonide
trolamine salicylate
uptake
verteporfin
vitamin E
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557124003321
Pereira Maria Carmo  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Present and Future of Personalised Medicine for Endocrine Cancers
Present and Future of Personalised Medicine for Endocrine Cancers
Autore Ronchi Cristina L
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (140 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato adjuvant treatment
adrenal adenomas
adrenal cortex
adrenal tumors
adrenocortical cancer
aggressive PitNET
aggressive pituitary adenoma
aggressive pituitary tumor
angiogenesis
BRAF
BRAF V600E
carcinoma
Cushing's disease
differentiated thyroid cancer
focus group interview
gene expression
hyaluronan synthase 1
immune checkpoint inhibitors (ICIs)
information needs and preferences
intratumoral heterogeneity
ipilimumab
ki-67
lenvatinib
mitotane
molecular clusters
multikinase inhibitors
n/a
neuroendocrine tumours
nivolumab
osteopontin
p27
p53
papillary thyroid cancer
paraganglioma
personalized medicine
phaeochromocytoma
pituitary carcinoma
predictive marker
predictors
prolactinoma
radioiodine resistance
RAS mutation
recurrence
recurrence free survival
response to treatment
RET/PTC rearrangements
reticulin
sorafenib
survival
SUV PET/CT
thyroid tumor
timing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576879703321
Ronchi Cristina L  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui